Which sedation works best for stent removal? new study compares options

NCT ID NCT07580768

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested three sedation approaches for removing a Double-J ureteral stent, a common procedure. Sixty adults received either propofol alone, propofol plus dexmedetomidine, or propofol plus midazolam. Researchers measured total propofol use and sedation levels to find the most effective and safe combination.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Propofol, dexmedetomidine, midazolam
What this could lead to
If successful, this could identify a safer or more effective sedation combination for a common urological procedure.
What could go wrong
This is a small, completed trial with 60 participants, so results may not apply broadly. Sedation risks like breathing problems or low blood pressure are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEXMEDETOMIDINE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Tanta University

    Tanta, El-Gharbia, 31527, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.